Illumina Ventures pursues investments in early stage companies that are pioneering new applications of nucleic acid sequencing, developing products that will expand the genomics ecosystem, and utilizing genomics to improve human health.
Phone: 858-210-1824
499 Illinois Street
Suite 210
San Francisco, 94158
California, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-08-08 | SQZ Biotech | Series C - II | $72M | Bridger Healthcare, Everblue Management, Google Ventures, Invus Group, JMCR Partners, NanoDimension, and Polaris Partners |
| 2018-05-08 | Luna DNA | Series A | $2M | ARCH Venture Partners, Aristides Patrinos, Bridgelink Capital, and Hemisphere Ventures |
| 2018-03-21 | Cernostics | Series A - II | $2.5M | |
| 2018-02-22 | Kallyope | Series B | $66M | Alexandria Venture Investments, Euclidean Capital, Lux Capital, Polaris Partners, The Column Group, and Two Sigma Ventures |
| 2018-02-06 | Baebies | Series B - III | $2.76M |
